Precision screening identifies mitoxantrone as a multitarget inhibitor in ageing-associated cancers with extensive computational validation and doxorubicin comparison. - Al-Qahtani, Mohammed H.; Assidi, Mourad; Buhmeida, Abdelbaset; Almuhammadi, Asma; Pushparaj, Peter Natesan; Alganmi, Nofe Ateq (PLoS ONE, 2026)